Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
Authors:
Open Access
- 20 October 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 576314
Abstract
Body composition refers to the proportional content of body fat mass and lean body mass that can lead to a continuum of different phenotypes ranging from cachectic/sarcopenic state to obesity. The heterogenetic phenotypes of body composition can contribute to formation of some cancer types and can sometimes lead to disparate outcomes. Both of these extremes of the spectrum exist in patients with non-small cell lung carcinoma (NSCLC). The discovery of new pathways that drive tumorigenesis contributing to cancer progression and resistance have expanded our understanding of cancer biology leading to development of new targeted therapies including tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors (ICI) that have changed the landscape of NSCLC treatment. However, in the new era of precision medicine, the impact of body composition phenotypes on treatment outcomes and survival is now being elucidated. In this review, we will discuss the emerging evidence of a link between body composition and outcomes in patients with NSCLC treated with TKI and ICI. We will also discuss suggested mechanisms by which body composition can impact tumor behavior and anti-tumor immunological response.Keywords
This publication has 119 references indexed in Scilit:
- Obesity and Weight Loss at Presentation of Lung Cancer are Associated with Opposite Effects on SurvivalJournal of Surgical Research, 2011
- Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung CarcinomaCancer Research, 2011
- Sarcopenia as a Prognostic Factor among Patients with Stage III MelanomaAnnals of Surgical Oncology, 2011
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)Journal of Clinical Oncology, 2011
- Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysisCancer Prevention Research, 2011
- Role of TGF-β signaling in inherited and acquired myopathiesSkeletal Muscle, 2011
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 BlockadeSeminars in Oncology, 2010
- The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancerBMC Cancer, 2010
- Accuracy of body mass index in diagnosing obesity in the adult general populationInternational Journal of Obesity, 2008
- Expression of interleukin‐15 in human skeletal muscle – effect of exercise and muscle fibre type compositionThe Journal of Physiology, 2007